Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations

Benefit and Risk of Prolonged Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents in Patients With Elevated Lipoprotein(a) Concentrations

Background: Lipoprotein(a) is positively related to cardiovascular events in patients with coronary artery disease (CAD). Given that lipoprotein(a) has a prothrombotic effect, prolonged dual antiplatelet therapy (DAPT) might have a beneficial effect on reducing ischemic events in patients with eleva...

Full description

Bibliographic Details
Main Authors: Kongyong Cui, Hao-Yu Wang, Dong Yin, Chenggang Zhu, Weihua Song, Hongjian Wang, Lei Jia, Dong Zhang, Chenxi Song, Lei Feng, Kefei Dou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
lipoprotein(a) [Lp(a)]
coronary artery disease
percutaneous coronary intervention (or PCI)
drug-eluting stent (DES)
DAPT (dual antiplatelet therapy)
clinical outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.807925/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.807925/full

Similar Items